Here’s a plot twist nobody saw coming: Palantir just delivered one of the most impressive earnings reports in company history, and the stock tanked anyway. Welcome to the weird world of mega-growth stocks, where crushing expectations somehow feels like a disappointment.
Let’s talk numbers first, because they’re genuinely wild. Palantir’s Q1 2026 revenue jumped 85% year-over-year to $1.633 billion—the fastest growth the company has ever posted. But here’s where it gets spicy: they’re actually profitable. Adjusted operating income hit $984 million with a 60% margin. That’s not just good; that’s “print it on a t-shirt” good. The company even posted a Rule of 40 score of 145%, which CEO Alex Karp basically celebrated by saying they “shattered the metric.”
Management also raised guidance for the rest of 2026. Everything pointed to a victory lap. Instead, PLTR stock dropped about 6% after earnings and is now down 22% year-to-date.
So what gives?
According to one investor (who goes by CAN Analyst), the market’s expectations have gotten so absurdly high that even exceptional results feel like a letdown. “The results were actually good, but they were not good enough for the current share price,” they explained. It’s like showing up to a party with a premium bottle of wine and someone complaining it’s not vintage enough.
The real issue? Valuation. When a stock has already surged 1,680% over three years, the bar doesn’t just get higher—it enters the stratosphere. At that point, investors start playing a different game. Instead of celebrating wins, they’re looking for reasons to sell. It’s the classic “sell the news” mentality that kicks in when stocks enter overvalued territory.
CAN Analyst ran the numbers with what they called “optimistic” assumptions: 30% revenue growth annually over five years and a 48% free cash flow margin. Even with those rosy projections, they calculated a potential 58% downside for PLTR shares. Their verdict? “I do not see good risk to reward here.” They rated the stock a Sell.
Wall Street, though, isn’t buying the pessimism. The consensus is a Moderate Buy, with 13 Buy ratings, 4 Holds, and 2 Sells. Analysts have a 12-month price target of $187.56, suggesting 36% upside from current levels.
Here’s the thing: Palantir is genuinely executing at an elite level. The company is growing like a startup while maintaining profitability like a mature business. That’s rare. But the market doesn’t care about fundamentals when a stock has already run this far. It cares about whether the next quarter will be even more impressive than the last one.
It’s a trap that catches a lot of high-flyers. You can do everything right and still disappoint investors who’ve already priced in perfection. For Palantir shareholders, that’s the real problem—not the business, but the expectations game.
